NEW YORK (GenomeWeb) – A federal court this week preliminarily approved an agreement in which Celera will pay former shareholders $23 million to settle a five-year-old lawsuit that alleged the company made materially false and misleading financial statements, inflating its stock price. 

As part of the decision handed down on Tuesday by the US District Court for the Northern District of California, co-defendant PriceWaterhouseCoopers has also agreed to pay $1.75 million to settle the litigation. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.